The OASIS Trial: Efficacy and Safety Outcomes in Subjects With Full-Thickness Macular Hole

Related

• 

  Gene Expression Modifications in Anti-VEGF Treated Retinal Müller Cells

  Baruch D. Kuppermann, MD, PhD

  Annual Meeting Talks

  2016

• 

  Long Term Results of Pro Re Nata Regimen of Aflibercept Treatment in Recurrent or Persistent Neovascular Age-Releated Macular Degeneration

  ILKAY KILIC MUFTUOGLU, MD

  Annual Meeting Talks

  2016

• 

  Macular Surgery Expert Panel

  Carl C. Awh, MD, FASRS

  Grazia Pertile

  Zofia Anna Nawrocka (vel Michalewska), MD, PhD

  Peiquan Zhao, MD

  Tamer H. Mahmoud, MD, PhD

  Annual Meeting Talks

  2016